New Insights Into How the Intestine Can Regulate Lipid Homeostasis and Impact Vascular Disease: Frontiers for New Pharmaceutical Therapies to Lower Cardiovascular Disease Risk (Q37860660)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 1, 2011

Language	Label	Description	Also known as
English	New Insights Into How the Intestine Can Regulate Lipid Homeostasis and Impact Vascular Disease: Frontiers for New Pharmaceutical Therapies to Lower Cardiovascular Disease Risk	scientific article published on March 1, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

New insights into how the intestine can regulate lipid homeostasis and impact vascular disease: frontiers for new pharmaceutical therapies to lower cardiovascular disease risk (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

New Insights Into How the Intestine Can Regulate Lipid Homeostasis and Impact Vascular Disease: Frontiers for New Pharmaceutical Therapies to Lower Cardiovascular Disease Risk (English)

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

cardiovascular disease

1 reference

based on heuristic

inferred from title

vascular disease

1 reference

based on heuristic

inferred from title

3

object named as

Khosrow Adeli

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21459267

29 November 2024

Spencer Proctor

6

object named as

Spencer D. Proctor

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21459267

29 November 2024

author name string

Samantha Warnakula

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Joanne Hsieh

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Patrick Tso

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

M. Mahmood Hussain

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21459267

29 November 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21459267

29 November 2024

publication date

1 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

March 2011

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21459267

29 November 2024

number of pages

9

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:S0828282X1000036X?httpAccept=text/xml

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

https://api.elsevier.com/content/article/PII:S0828282X1000036X?httpAccept=text/plain

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

The Canadian Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

183-191

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Triglycerides and atherosclerosis: to feast or fast

3

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis.

4

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis

5

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Postprandial lipoproteins and progression of coronary atherosclerosis

6

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Remnant lipoproteins and atherosclerosis

7

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits.

8

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy.

9

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?

10

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins

11

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes

13

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Postprandial lipemia as an early predictor of cardiovascular complications in childhood obesity.

14

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Effects of triacylglycerol-saturated acyl chains on the clearance of chylomicron-like emulsions from the plasma of the rat.

15

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Plasma clearance of model lipoproteins containing saturated and polyunsaturated monoacylglycerols injected intravenously in the rat

16

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Chylomicrons in disease-future challenges Invited keynote address

17

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

High cholesterol intake modifies chylomicron metabolism in normolipidemic young men

19

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Food restriction normalizes chylomicron remnant metabolism in murine models of obesity as assessed by a novel stable isotope breath test

20

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Effects of adrenaline and noradrenaline on clearance of triacylglycerol-rich lipoproteins from plasma: studies with chylomicron-like lipid emulsions in rats

21

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Effects of adrenoreceptor antagonists and agonists on clearance of emulsion models of triacylglycerol-rich lipoproteins from plasma in rats

22

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Vasoactive mediators affect the clearance of lipids from emulsion models of plasma lipoproteins in rats

23

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Remnant lipoprotein metabolism is improved more when body weight is reduced by exercise than by dietary restriction

24

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Vesicle-associated membrane protein 7 is expressed in intestinal ER

25

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

The identification of a novel endoplasmic reticulum to Golgi SNARE complex used by the prechylomicron transport vesicle

26

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Very low density lipoproteins in intestinal lymph: role in triglyceride and cholesterol transport during fat absorption

28

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Lipoproteins associated with the Golgi apparatus isolated from epithelial cells of rat small intestine

29

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Oral fat exposure alters postprandial lipid metabolism in humans

30

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Oral fat exposure increases the first phase triacylglycerol concentration due to release of stored lipid in humans

31

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Meal ingestion provokes entry of lipoproteins containing fat from the previous meal: possible metabolic implications

32

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Evidence for separate pathways of chylomicron and very low-density lipoprotein assembly and transport by rat small intestine

33

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Assembly and secretion of chylomicrons by differentiated Caco-2 cells. Nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly

34

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Formation and transport of chylomicrons by enterocytes to the lymphatics

35

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Progress in absorption enhancers based on tight junction

36

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Do surface-active lipids in food increase the intestinal permeability to toxic substances and allergenic agents?

37

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Jejunal mucosal injury and restitution: role of hydrolytic products of food digestion

38

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons

39

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

A proposed model for the assembly of chylomicrons

40

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Intestinal microsomal triglyceride transfer protein in type 2 diabetic and non-diabetic subjects: the relationship to triglyceride-rich postprandial lipoprotein composition

42

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

The Role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes

43

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Microsomal triglyceride transfer protein: does insulin resistance play a role in the regulation of chylomicron assembly?

44

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes.

45

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster

46

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Intestinal lipid absorption

47

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Multiple, independently regulated pathways of cholesterol transport across the intestinal epithelial cells

48

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Rat Intestine Secretes Discoid High Density Lipoprotein

49

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Intestinal ABCA1 directly contributes to HDL biogenesis in vivo

50

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Evidence for multiple complementary pathways for efficient cholesterol absorption in mice

51

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

IRE1beta inhibits chylomicron production by selectively degrading MTP mRNA.

52

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up

53

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

54

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Blood lipid concentrations and risk of myocardial infarction

55

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Dietary fat, fatty acid composition in plasma and the metabolic syndrome

56

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Cardiovascular disease in type 2 diabetes mellitus: current management guidelines

57

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein, and albumin

58

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Arterial intimal retention of pro-atherogenic lipoproteins in insulin deficient rabbits and rats

59

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Chylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndrome.

60

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome

61

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Intestinal lipid transport and chylomicron production: possible links to exacerbated atherogenesis in a rodent model of the metabolic syndrome.

62

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Acute hyperinsulinism modulates plasma apolipoprotein B-48 triglyceride-rich lipoproteins in healthy subjects during the postprandial period

63

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related ki

64

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-contain

65

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Proteomic profiling of intestinal prechylomicron transport vesicle (PCTV)-associated proteins in an animal model of insulin resistance (94 char).

66

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins

67

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Incretins and the development of type 2 diabetes

68

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

The biology of incretin hormones

69

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans

70

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats

71

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice

72

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver

73

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

74

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats

75

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans

76

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36.

77

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Leptin secretion and leptin receptor in the human stomach

78

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Leptin action in intestinal cells

79

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Overexpression of apolipoprotein A-IV enhances lipid secretion in IPEC-1 cells by increasing chylomicron size

80

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

An intrinsic gut leptin-melanocortin pathway modulates intestinal microsomal triglyceride transfer protein and lipid absorption

81

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia

82

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia

83

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans

84

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Pluronic L-81 ameliorates diabetic symptoms in db/db mice through transcriptional regulation of microsomal triglyceride transfer protein.

85

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Efficacy and safety of disodium ascorbyl phytostanol phosphates in men with moderate dyslipidemia

86

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.

87

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks

88

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition

89

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo

90

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial.

91

1 reference

10.1016/J.CJCA.2010.12.020

https://api.crossref.org/works/10.1016/J.CJCA.2010.12.020

29 November 2024

Identifiers

10.1016/J.CJCA.2010.12.020

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37860660&oldid=2280993470"